Congenital adrenal hyperplasia: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 52: Line 52:


'''Prevention:''' [[Congenital adrenal hyperplasia primary prevention|Primary prevention]] | [[Congenital adrenal hyperplasia secondary prevention|Secondary prevention]]
'''Prevention:''' [[Congenital adrenal hyperplasia primary prevention|Primary prevention]] | [[Congenital adrenal hyperplasia secondary prevention|Secondary prevention]]
==CAH due to 21-hydroxylase deficiency==
*[[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency#Overview|Overview]]
*[[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency#Genetics, inheritance, and incidence|Genetics, inheritance, and incidence]]
*[[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency#Pathophysiology|Pathophysiology]]
*'''Clinical onset:''' [[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency#Severe, early onset 21-hydroxylase deficient CAH|Early onset]] | [[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency#Childhood onset (simple virilizing) CAH|Childhood onset]] | [[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency#Late onset (nonclassical) CAH|Late onset]]


==Related chapters==
==Related chapters==

Revision as of 20:31, 18 January 2012

For patient information click here

Congenital adrenal hyperplasia
Cortisol
ICD-10 E25.0
ICD-9 255.2
OMIM 201910 201710 202110 201810 202010
DiseasesDB 1854 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2
MedlinePlus 000411
MeSH D000312

Congenital adrenal hyperplasia main page

Overview

Classification

21-hydroxylase deficiency
11β-hydroxylase deficiency
17 alpha-hydroxylase deficiency
3 beta-hydroxysteroid dehydrogenase deficiency
Cytochrome P450-oxidoreductase (POR) deficiency (ORD)
Lipoid congenital adrenal hyperplasia

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Classification

Types of CAH | Genetics | Biochemistry

Historical perspective

Pathophysiology

Epidemiology & demographics

Risk factors

Screening

Causes

Differentiating congenital adrenal hyperplasia from other diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms | Physical examination | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical therapy: 21-Hydroxylase | 11-Hydroxylase

Surgical therapy: Surgery

Prevention: Primary prevention | Secondary prevention

CAH due to 21-hydroxylase deficiency

Related chapters

Resources


de:Adrenogenitales Syndrom it:Iperplasia surrenale congenita nl:Adrenogenitaal syndroom


Template:WikiDoc Sources